National Bank of Canada’s Eli Lilly LLY Stock Holding History

National Bank of Canada’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21M	Sell	228 -486	-68%	-$493K	0.02%	481
2025 Q4	$76.7M	Sell	714 -258	-27%	-$247K	0.07%	235
2025 Q3	$74.2M	Sell	972 -3,087	-76%	-$2.3M	0.07%	220
2025 Q2	$316M	Buy	4,059 +3,559	+712%	+$2.77M	0.3%	63
2025 Q1	$41.3M	Sell	500 -936	-65%	-$779K	0.04%	342
2024 Q4	$111M	Buy	1,436 +736	+105%	+$609K	0.12%	169
2024 Q3	$62M	Buy	700 +699	+69,900%	+$628K	0.07%	252
2024 Q2	$91.4K	Buy	+1	New	+$800	﹤0.01%	1514

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

National Bank of Canada's LLY Position: Q1 2026 in Review

National Bank of Canada reduced its Eli Lilly (LLY) stake by 0.72% in Q1 2026, selling an estimated $4.58M and leaving 620,178 shares worth $570M. The position accounts for 0.51% of the portfolio, ranked #41.

National Bank of Canada first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $817M in Q2 2025. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

National Bank of Canada held 620,178 shares of Eli Lilly worth $570M as of Q1 2026.
National Bank of Canada sold 4,520 Eli Lilly shares in Q1 2026, an estimated $4.58M.
Eli Lilly made up 0.51% of National Bank of Canada's portfolio in Q1 2026, its #41 holding.
National Bank of Canada first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
National Bank of Canada's Eli Lilly position peaked at $817M in Q2 2025.
4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.